Etomidate

Etomidate · ETOMIDATE 2 mg/mL · Injection · Intravenous · Civica, Inc.

NDC 72572-0160-10 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$36.30

Reported to Texas DSHS · 2026 annual filing · Civica, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Hikma Farmaceutica (Portugal), S.aPortugal
analysis · label · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: ANDA202354
TE code: AP
Approval date: Feb 25, 2016
Patents / exclusivity: None on file

Shortage history

In shortage now — Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months
In shortage now — Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10)Oct 5, 2022
month 47 — 2× the typical 20-month injectable shortage · model puts 30% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Etomidate (Injection)

Labeler	Strength	First seen	Last seen
Civica, Inc.	ETOMIDATE 2 mg/mL	Jul 15, 2026	Sep 3, 2026
Hikma Pharmaceuticals USA Inc.	ETOMIDATE 2 mg/mL	Jul 15, 2026	Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirst	ETOMIDATE 2 mg/mL	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Etomidate — NDC 72572-0160-10," retrieved September 3, 2026, https://drugdashboards.com/drug/72572016010.

Free to cite with attribution — see how the data is put together.